Skin and nail responses after 1 year of infliximab therapy in patients with moderate-to-severe psoriasis: A retrospective analysis of the EXPRESS trial

Dermatology

Volumn 221, Issue 2, 2010, Pages 172-178

  Reich, Kristian ^a   Ortonne, Jean Paul ^b   Kerkmann, Urs ^c   Wang, Yanxin ^d   Saurat, Jean Hilaire ^e   Papp, Kim ^f   Langley, Richard ^g   Griffiths, Christopher E M ^h  

^a Dermatologikum   (Germany)

^b CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

^c Centocor BV   (Netherlands)

^d MERCK RESEARCH LABORATORIES   (United States)

^e GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^f PROBITY MEDICAL RESEARCH   (Canada)

^g DALHOUSIE UNIVERSITY   (Canada)

^h UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Biologic agent; Infliximab; Nail psoriasis; Nail Psoriasis Severity Index; Psoriasis

Indexed keywords

INFLIXIMAB;

ADULT; ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; DISEASE SEVERITY; DRUG WITHDRAWAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NAIL PSORIASIS; PRIORITY JOURNAL; PSORIASIS; PSORIASIS SEVERITY INDEX; QUALITY OF LIFE; RETROSPECTIVE STUDY; TREATMENT DURATION; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

ADULT; ANTIBODIES, MONOCLONAL; CLINICAL TRIALS, PHASE III AS TOPIC; DERMATOLOGIC AGENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTICENTER STUDIES AS TOPIC; NAILS; PSORIASIS; QUALITY OF LIFE; RETROSPECTIVE STUDIES; SKIN; TREATMENT OUTCOME;

EID: 77956343215     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000317775     Document Type: Article

References (15)

1. Reich K, Nestle FO, Papp K, Ortonne JP, Evans R, Guzzo C, Li S, Dooley LT, Griffiths CE, EXPRESS study investigators: Infliximab induction and maintenance therapy for moderate-to-severe psoriasis: a phase III, multicentre, double-blind trial. Lancet 2005; 366: 1367-1374.
2. Reich K, Nestle FO, Papp K, Ortonne JP, Wu Y, Bala M, Evans R, Guzzo C, Li S, Dooley LT, Griffiths CE: Improvement in quality of life with infliximab induction and maintenance therapy in patients with moderate-to-severe psoriasis: a randomized controlled trial. Br J Dermatol 2006; 154: 1161-1168.
3. Rich P, Griffiths CE, Reich K, Nestle FO, Scher RK, Li S, Xu S, Hsu MC, Guzzo C: Baseline nail disease in patients with moderate to severe psoriasis and response to treatment with infliximab during 1 year. J Am Acad Dermatol 2008; 58: 224-231.
4. De Jong EMGJ, Seegers BAMPA, Gulinck MK, Boezeman JBM, van de Kerkhof PCM: Psoriasis of the nails associated with disability in a larger number of patients: results of a recent interview with 1,728 patients. Dermatology 1996; 193: 300-303.
5. Farber EM, Nall L: Nail psoriasis. Cutis 1992; 50: 174-178.
6. Fredriksson T, Pettersson U: Severe psoriasis - oral therapy with a new retinoid. Dermatologica 1978; 157: 238-244.
7. Finlay AY, Khan GK: Dermatology Life Quality Index (DLQI): a simple practical measure for routine clinical use. Clin Exp Dermatol 1994; 19: 210-216.
8. Augustin M, Kruger K, Radtke MA, Schwippl I, Reich K: Disease severity, quality of life and health care in plaque-type psoriasis: a multicenter cross-sectional study in Germany. Dermatology 2008; 216: 366-372.
9. Williamson L, Dalbeth N, Dockerty JL, Gee BC, Weatherall R, Wordsworth BP: Extended report: nail disease in psoriatic arthritis - clinically important, potentially treatable and often overlooked. Rheumatology (Oxf) 2004; 43: 790-794.
10. Wilson FC, Icen M, Crowson CS, McEvoy MT, Gabriel SE, Kremers HM: Incidence and clinical predictors of psoriatic arthritis in patients with psoriasis: a population-based study. Arthritis Rheum 2009; 61: 233-239.
11. Kerkmann U, Winkelman W, Wang Y, Reich K: Target nail NAPSI correlates with number of nails involved: a clinically efficient, useful, and precise assessment for nail psoriasis severity (poster 1164). 18th Congr Eur Acad Dermatol Venereol, Berlin, October 2009.
12. McGonagle D, Tan AL, Benjamin M: The nail as a musculoskeletal appendage - implications for an improved understanding of the link between psoriasis and arthritis. Dermatology 2009; 218: 97-102.
13. Tan AL, Benjamin M, Toumi H, Grainger AJ, Tanner SF, Emery P, McGonagle D: The relationship between the extensor tendon enthesis and the nail in distal interphalangeal joint disease in psoriatic arthritis - a high-resolution MRI and histological study. Rheumatology (Oxf) 2007; 46: 253-256.
14. Antoni C, Krueger GG, de Vlam K, Birbara C, Beutler A, Guzzo C, Zhou B, Dooley LT, Kavanaugh A, IMPACT 2 Trial Investigators: Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial. Ann Rheum Dis 2005; 64: 1150-1157.
15. Ritchlin CT, Kavanaugh A, Gladman DD, Mease PJ, Helliwell P, Boehncke WH, de Vlam K, Fiorentino D, Fitzgerald O, Gottlieb AB, McHugh NJ, Nash P, Qureshi AA, Soriano ER, Taylor WJ, Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): Treatment recommendations for psoriatic arthritis. Ann Rheum Dis 2009; 68: 1387-1394.